TRAITEMENT DE MALADIES ASSOCIÉES AUX GÈNES DU MÉTABOLISME ET DU TRANSPORT DES LIPIDES PAR INHIBITION DE TRANSCRIT ANTISENS NATUREL D'UN GÈNE DU MÉTABOLISME ET DU TRANSPORT DES LIPIDES
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of a Lipid transport and metabolism gene, in particular, by targeting natural antisense polynucleotides of a Lipid transport and metabolism gene. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of a Lipid transport and metabolism genes.
